IRB #

IRB00008410

Title

The development of the ovarian cancer genome

Principal Investigator

Paul Spellman

Study Purpose

The most common and lethal ovarian cancer shows only a handful of cancer causing point mutations in each patient’s tumor. Instead, tumors development appears to be dependent on altering the structure of the genome. We propose to use new methods that we developed to understand when changes in the ovarian cancer genome occur and use this knowledge to develop tests for early detection of ovarian tumors and to identify therapies effective against these early tumors.

Medical Condition(s)

Ovarian Cancer

Eligibility Criteria

Patients diagnosed with ovarian cancer

Age Range

18 - over 18

Healthy Volunteers Needed

No

Duration of Participation

Up to 60 months (annual questionnaires).

Minors Included

No

Contact

Tara Macey, Ph.D.
503-494-9895
maceyt@ohsu.edu

Sponsor

Anna Fuller Foundation

Recruitment End

Compensation Provided

No